Hogy Medical Co Ltd
TSE:3593
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hogy Medical Co Ltd
TSE:3593
|
JP |
|
TCS Group Holding PLC
LSE:TCS
|
CY |
|
J
|
Juventus FC SpA
XBER:JUVE
|
IT |
|
Adyen NV
AEX:ADYEN
|
NL |
|
EFG Hermes Holdings SAE
LSE:EFGD
|
EG |
|
Enovix Corp
NASDAQ:ENVX
|
US |
|
C
|
Consti Oyj
OMXH:CONSTI
|
FI |
Wall St Price Targets
Price Targets Summary
Hogy Medical Co Ltd
According to Wall Street analysts, the average 1-year price target for Hogy Medical Co Ltd is 4 488 JPY with a low forecast of 3 939 JPY and a high forecast of 5 145 JPY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Hogy Medical Co Ltd's stock price target?
Price Target
4 488
JPY
According to Wall Street analysts, the average 1-year price target for Hogy Medical Co Ltd is 4 488 JPY with a low forecast of 3 939 JPY and a high forecast of 5 145 JPY.
What is the Revenue forecast for Hogy Medical Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 1%.
What is the Gross Profit forecast for Hogy Medical Co Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -2%. The projected CAGR for the next 3 years is 3%.
What is the Operating Income forecast for Hogy Medical Co Ltd?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been -5%. The projected CAGR for the next 13 years is 6%.
What is the Pre-Tax Income forecast for Hogy Medical Co Ltd?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -7%. The projected CAGR for the next 3 years is 15%.
What is the Net Income forecast for Hogy Medical Co Ltd?
Projected CAGR
30%
Over the last 13 years, the compound annual growth rate for Net Income has been -8%. The projected CAGR for the next 3 years is 30%.